Aura Biosciences NMIBC Data at EAU Congress
Aura Biosciences announced Phase 1 data from its trial of bel-sar (AU-011) for non-muscle invasive bladder cancer (NMIBC) will...
Voyager Reports Positive Topline Anti-Tau Antibody Data, Initiates Next Trial
Voyager Therapeutics announced positive topline data from its single ascending dose (SAD) trial of VY7523, an investigational anti-tau antibody...
Traws Pharma Reports Positive Bird Flu Results for Tivoxavir
Traws Pharma announced positive topline results from a ferret study of tivoxavir marboxil, a single-dose oral antiviral for bird...
Deucrictibant Data at AAAAI/WAO 2025: HAE Prevention & Treatment
Pharvaris released positive long-term data for its oral bradykinin B2 receptor antagonist, deucrictibant, at the 2025 AAAAI/WAO Joint Congress....
Apg990 Interim Phase 1 Results Show Potential for Maintenance Dosing
Apogee Therapeutics announced positive interim Phase 1 results for APG990, a novel, half-life extended OX40L antibody, demonstrating an approximately...
Lexicon Announces Pilavapan Results for Diabetic Nerve Pain
Lexicon Pharmaceuticals will announce topline results from its Phase 2b PROGRESS study of pilavapadin (LX9211) for diabetic peripheral neuropathic...
Y-mAbs Phase 2 Results Published in Nature Communications
Y-mAbs Therapeutics announced interim Phase 2 trial data published in Nature Communications, showing naxitamab combined with GM-CSF is effective...
DM Clinical Research Data Breach Exposes Over 1.6M Records, Raising Patient Privacy Concerns
DM Clinical Research, a Texas-based clinical trial site network, has suffered a major data breach, exposing over 1.6 million...
Seoul Semiconductor’s Natural Light Revolutionizes Lighting
Seoul Semiconductor will showcase its SunLike LED technology, designed to mimic natural light, at JAPAN SHOP 2025 in Tokyo....
Milestone Reached: First Patient Treated with EG110A for Neurogenic Bladder
EG 427 has dosed the first patient in its Phase 1b/2a clinical trial of EG110A, a novel gene therapy...